WEDNESDAY, May 16 (HealthDay News) -- A new targeted drug therapy may help treat certain advanced cancers in children, a new preliminary study indicates. full story ![]()
(Reuters) - An experimental drug that spurs the immune system to fight cancer appeared to be safe and demonstrated anti-tumor activity against a variety of cancers in a small early stage study, researchers said on Tuesday.
reuters.com (1 month and 11 days ago)
In a study involving about 10,000 people, the new test detected 92 percent of the cancers picked up by colonoscopy, according to the company that makes the test.
nytimes.com (1 month and 2 days ago)
About one-third of chemotherapies are used to fight cancers that drug regulators never approved them to treat, says a new study
foxnews.com (3 months ago)

About one-third of chemotherapies are used to fight cancers that drug regulators never approved them to treat, says a new study.
chicagotribune.com (3 months and 1 day ago)

(Reuters) - A study in rats and monkeys suggests an experimental Merck & Co. sleep drug may help induce sleep without causing the memory loss and attention problems sometimes seen in the
denverpost.com (1 month and 16 days ago)
NEW YORK (Reuters Health) - About one-third of chemotherapies are used to fight cancers that drug regulators never approved them to treat, says a new study.
reuters.com (3 months and 1 day ago)
CHICAGO (Reuters) - A study in rats and monkeys suggests an experimental Merck & Co sleep drug may help induce sleep without causing the memory loss and attention problems sometimes seen in the commonly used drugs Ambien and Lunesta, company researchers said on Wednesday.
reuters.com (1 month and 17 days ago)
Higher levels of traffic air pollution during pregnancy and 1 year of life linked to three childhood cancers
cbsnews.com (1 month and 10 days ago)
For the elderly, not only can even supposedly minor procedures have complications, but the cancers grow so slowly that they’re unlikely to cause problems in the patients’ remaining years.
nytimes.com (15 days ago)

Industry analysts say the drug, Ibrutinib, has mostly flown under the radar because of its niche market, but still believe it holds significant potential because of its unique technology and relatively mild side effects
nj.com (1 month and 6 days ago)
Watch the new trailer for Hugh Jackman's...
New trailer for Superman reboot 'Man Of...
Drake spotted filming cameo for...
Tulisa quits as a judge on The X Factor
The Rolling Stones' Keith Richards...
David Bowie pays tribute to late Spiders...
Matt Damon Launches Bathroom Strike for...
Peter Webber to Direct Rose Tremain's...
Cannes: Strand Releasing Grabs 'Stranger...
Cannes: Weinstein's Radius Picks Up...
New Man of Steel trailer released
Cannes 2013: The Great Beauty, review
Man dies after police-involved shooting...
Portland, Ore., rejecting water...
Kaitlyn Hunt pleads not guilty to...
Susan Powell case: Police say husband...
Rare 'Harry Potter' first edition...
Immigration bill clears key Senate panel
Tacky or just plain weird? Gallery in...
Baz Luhrmann hails Great Gatsby at...
Cannes Film Festival: Did Cara...
From dressing gown to glamour - Sharon...
Elton John to close this summer's Hyde...
Blue flag beaches down in Britain
Piazzas, panoramic views a sprinkling of...
Michael Morpurgo's Ypres: My Kind of Town
Hay Festival 2013 preview: Ireland's...
Tell us about your favourite waterfalls
AN AUSSIE doctor has climbed Everest, making him part of a select group that has successfully...
Here are ten of the most significant studies on staving off Alzheimer's, with an expert verdict...